Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $1.90 billion. The enterprise value is $10.12 billion.
Important Dates
The last earnings date was Thursday, February 12, 2026, before market open.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | Feb 23, 2026 |
Share Statistics
Organon & Co. has 260.32 million shares outstanding. The number of shares has increased by 0.62% in one year.
| Current Share Class | 260.32M |
| Shares Outstanding | 260.32M |
| Shares Change (YoY) | +0.62% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 76.98% |
| Float | 259.03M |
Valuation Ratios
The trailing PE ratio is 10.13 and the forward PE ratio is 2.10. Organon & Co.'s PEG ratio is 0.86.
| PE Ratio | 10.13 |
| Forward PE | 2.10 |
| PS Ratio | 0.31 |
| Forward PS | 0.30 |
| PB Ratio | 2.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 2.71 |
| PEG Ratio | 0.86 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 54.14 |
| EV / Sales | 1.63 |
| EV / EBITDA | 6.12 |
| EV / EBIT | 7.83 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 11.70.
| Current Ratio | 1.82 |
| Quick Ratio | 0.84 |
| Debt / Equity | 11.70 |
| Debt / EBITDA | 5.10 |
| Debt / FCF | n/a |
| Interest Coverage | 2.57 |
Financial Efficiency
Return on equity (ROE) is 30.56% and return on invested capital (ROIC) is 6.24%.
| Return on Equity (ROE) | 30.56% |
| Return on Assets (ROA) | 6.22% |
| Return on Invested Capital (ROIC) | 6.24% |
| Return on Capital Employed (ROCE) | 12.34% |
| Weighted Average Cost of Capital (WACC) | 3.36% |
| Revenue Per Employee | $621,600 |
| Profits Per Employee | $18,700 |
| Employee Count | 10,000 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.08 |
Taxes
In the past 12 months, Organon & Co. has paid $238.00 million in taxes.
| Income Tax | 238.00M |
| Effective Tax Rate | 56.00% |
Stock Price Statistics
The stock price has decreased by -52.91% in the last 52 weeks. The beta is 0.55, so Organon & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -52.91% |
| 50-Day Moving Average | 7.94 |
| 200-Day Moving Average | 8.82 |
| Relative Strength Index (RSI) | 41.11 |
| Average Volume (20 Days) | 4,955,258 |
Short Selling Information
The latest short interest is 17.55 million, so 6.74% of the outstanding shares have been sold short.
| Short Interest | 17.55M |
| Short Previous Month | 15.54M |
| Short % of Shares Out | 6.74% |
| Short % of Float | 6.77% |
| Short Ratio (days to cover) | 2.80 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.22 billion and earned $187.00 million in profits. Earnings per share was $0.72.
| Revenue | 6.22B |
| Gross Profit | 3.38B |
| Operating Income | 1.29B |
| Pretax Income | 425.00M |
| Net Income | 187.00M |
| EBITDA | 1.65B |
| EBIT | 1.29B |
| Earnings Per Share (EPS) | $0.72 |
Full Income StatementBalance Sheet
The company has $574.00 million in cash and $8.80 billion in debt, with a net cash position of -$8.23 billion or -$31.60 per share.
| Cash & Cash Equivalents | 574.00M |
| Total Debt | 8.80B |
| Net Cash | -8.23B |
| Net Cash Per Share | -$31.60 |
| Equity (Book Value) | 752.00M |
| Book Value Per Share | 2.89 |
| Working Capital | 1.96B |
Full Balance SheetCash Flow
| Operating Cash Flow | 700.00M |
| Capital Expenditures | -162.00M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 54.34%, with operating and profit margins of 20.80% and 3.01%.
| Gross Margin | 54.34% |
| Operating Margin | 20.80% |
| Pretax Margin | 6.84% |
| Profit Margin | 3.01% |
| EBITDA Margin | 26.61% |
| EBIT Margin | 20.80% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.08, which amounts to a dividend yield of 1.11%.
| Dividend Per Share | $0.08 |
| Dividend Yield | 1.11% |
| Dividend Growth (YoY) | -92.86% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 11.11% |
| Buyback Yield | -0.62% |
| Shareholder Yield | 0.48% |
| Earnings Yield | 9.85% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for Organon & Co. is $11.75, which is 61.18% higher than the current price. The consensus rating is "Hold".
| Price Target | $11.75 |
| Price Target Difference | 61.18% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 0.66% |
| EPS Growth Forecast (5Y) | 40.84% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.26 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 5 |
